Dual photosensitizers material for photodynamic theraphy
Source abstract
Abstract
Abstract Fluoride-based upconversion luminescent materials have the advantage of low phonon energy, which can effectively reduce the non-radiative transition process, so that materials have higher luminous efficiency than other matrix materials. The core–shell NaGdF4:Er3+, Yb3+ @NaGdF4:Tm3+, Yb3+ nanoparticals were synthesized by thermal decomposition method. The core–shell structure can effectively avoid the surface quenching effect, meanwhile, Tm3+ in the shell transmits part of the photons in its excited state to Er3+, effectively enhancing the red emission of Er3+ and improving the luminous efficiency of the samples as a whole. The samples were further coated with a layer of mesoporous silica(mSiO2), where the photosensitizer(PS) Ce6 (red light activated) and MC540 (blue-green light activated) were compounded on through covalent bonds and electrostatic forces, respectively. So that three visable lights include red, green, and blue are all emitted from the sample to activate the PSs to produce reactive oxygen species (ROS) under 980 nm laser irradiation. In cells experiments, the samples were modified with folic acid (FA), which can mediated the cancer cells to target endocytosis. Notable photodynamic therapy (PDT) efficiency was observed under this dual-photosensitizers composite samples for its ROS generation.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Photopolymerization techniques and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (54)
Show source-provided references
1. Theranostic probe based on lanthanide-doped nanoparticles for simultaneous in vivo dual-modal imaging and photodynamic therapy10.1002/adma.201202433 ↗
2. Generation of singlet oxygen by photoexcited Au25(SR)18 clusters10.1021/cm500260z ↗
3. Enhanced cellular ablation by attenuating hypoxia status and reprogramming tumor-associated macrophages via NIR light-responsive upconversion nanocrystals10.1021/acs.bioconjchem.8b00068 ↗
4. Platelet-facilitated photothermal therapy of head and neck squamous cell carcinoma10.1002/anie.201709457 ↗
5. Near-infrared upconversion mesoporous cerium oxide hollow biophotocatalyst for concurrent pH-/H2O2 -responsive O2 -evolving synergetic cancer therapy10.1002/adma.201704833 ↗
6. Engineered upconversion nanoparticles for resolving protein interactions inside living cells10.1002/anie.201603028 ↗
7. One-pot synthesis of PEGylated plasmonic MoO(3-x) hollow nanospheres for photoacoustic imaging guided chemo-photothermal combinational therapy of cancer10.1016/j.biomaterials.2015.10.048 ↗
8. Ultrasensitive in vivo detection of primary gastric tumor and lymphatic metastasis using upconversion nanoparticles10.1021/nn507433p ↗
9. Near-Infrared upconversion luminescence and bioimaging in vivo based on quantum dots10.1002/advs.201801834 ↗
10. Anti-stokes shift luminescent materials for bio-applications10.1039/C6CS00415F ↗
11. Controllable generation of free radicals from multifunctional heat-responsive nanoplatform for targeted cancer therapy10.1021/acs.chemmater.7b04841 ↗
12. Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles10.1016/j.biomaterials.2011.05.007 ↗
13. In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers10.1038/nm.2933 ↗
14. Resonance energy transfer in upconversion nanoplatforms for selective biodetection10.1021/acs.accounts.6b00382 ↗
15. Assembly of upconversion nanophotosensitizer in vivo to achieve scatheless real-time imaging and selective photodynamic therapy10.1016/j.biomaterials.2019.02.015 ↗
16. Homologous-targeting biomimetic nanoparticles for photothermal therapy and Nrf2-siRNA amplified photodynamic therapy against oral tongue squamous cell carcinoma10.1016/j.cej.2020.124268 ↗
17. Reactive oxygen species-responsive nanoparticles based on PEGlated prodrug for targeted treatment of oral tongue squamous cell carcinoma by combining photodynamic therapy and chemotherapy10.1021/acsami.8b08269 ↗
18. Controllable synthesis of NaYF(4) : Yb, Er upconversion nanophosphors and their application to in vivo imaging of caenorhabditis elegans10.1039/c0jm02854a ↗
19. A strategy to achieve efficient dual-mode luminescence of Eu(3+) in lanthanides doped multifunctional NaGdF(4) nanocrystals10.1002/adma.201000128 ↗
20. An efficient and user-friendly method for the synthesis of hexagonal-phase NaYF(4):Yb, Er/Tm nanocrystals with controllable shape and upconversion fluorescence10.1088/0957-4484/19/34/345606 ↗
21. Green synthesis of highly dispersed ytterbium and thulium co-doped sodium yttrium fluoride microphosphors for in situ light upconversion from near-infrared to blue in animals10.1016/j.jcis.2017.10.017 ↗
22. Simultaneous enhancement of red upconversion luminescence and CT contrast of NaGdF4:Yb, Er nanoparticles via Lu(3+) doping10.1039/C8NR06968A ↗
23. One-pot synthesis of ultrasmall β-NaGdF4 nanoparticles with enhanced upconversion luminescence10.1039/C9TC01323G ↗
24. Upconversion and anti-stokes processes with f and d Ions in solids10.1021/cr020357g ↗
25. Recent advances in the chemistry of lanthanide-doped upconversion nanocrystals10.1039/b809132n ↗
26. Rare earth fluoride nano-/microcrystals: synthesis, surface modification and application10.1039/c0jm00031k ↗
27. A single 808 nm near-infrared light-mediated multiple imaging and photodynamic therapy based on titania coupled upconversion nanoparticles10.1021/acs.chemmater.5b03136 ↗
28. G-C3N4 coated upconversion nanoparticles for 808 nm near-infrared light triggered phototherapy and multiple imaging10.1021/acs.chemmater.6b03598 ↗
29. Growth, thermal and spectral properties of Nd3+-doped NaGd(MoO4)2 crystal10.1016/j.jcrysgro.2006.02.005 ↗
30. Monodisperse NaYbF4:Tm3+/NaGdF4 core/shell nanocrystals with near-infrared to near-infrared upconversion photoluminescence and magnetic resonance properties10.1039/c0nr01018a ↗
31. Tunable near infrared to ultraviolet upconversion luminescence enhancement in (alpha-NaYF4 :Yb, Tm)/CaF2 core/shell nanoparticles for in situ real-time recorded biocompatible photoactivation10.1002/smll.201300234 ↗
32. Light upconverting core–shell nanostructures: nanophotonic control for emerging applications10.1039/C4CS00170B ↗
33. Active-core/active-shell nanostructured design: an effective strategy to enhance Nd3+/Yb3+ cascade sensitized upconversion luminescence in lanthanide-doped nanoparticles10.1039/C5TC01438G ↗
34. A dual-functional upconversion core@shell nanostructure for white-light-emission and temperature sensing10.1039/C6TC02218A ↗
35. Employing shells to eliminate concentration quenching in photonic upconversion nanostructure10.1039/C7NR01403A ↗
36. Multicolor tunable upconversion luminescence from sensitized seed-mediated grown LiGdF4:Yb, Tm-based core/triple-shell nanophosphors for transparent displays10.1021/acs.chemmater.8b02497 ↗
37. Theranostic micelles based on upconversion nanoparticles for dual-modality imaging and photodynamic therapy in hepatocellular carcinoma10.1039/C7NR09717D ↗
38. PDT-driven highly efficient intracellular delivery and controlled release of CO in combination with sufficient singlet oxygen production for synergistic anticancer therapy10.1002/adfm.201804324 ↗
39. Aptamer-based multifunctional ligand-modified UCNPs for targeted PDT and bioimaging10.1039/C8NR01096J ↗
40. Current advances in lanthanide ion (Ln(3+))-based upconversion nanomaterials for drug delivery10.1039/C4CS00155A ↗
41. A core–shell-shell nanoplatform upconverting near-infrared light at 808 nm for luminescence imaging and photodynamic therapy of cancer10.1038/srep10785 ↗
42. Covalently assembled NIR nanoplatform for simultaneous fluorescence imaging and photodynamic therapy of cancer cells10.1021/nn300436b ↗
43. A facile fabrication of upconversion luminescent and mesoporous core–shell structured β-NaYF4:Yb3+, Er3+@mSiO2nanocomposite spheres for anti-cancer drug delivery and cell imaging10.1039/C2BM00087C ↗
44. Functionalized mesoporous silica materials for controlled drug delivery10.1039/c2cs15308d ↗
45. Highly emissive dye-sensitized upconversion nanostructure for dual-photosensitizer photodynamic therapy and bioimaging10.1021/acsnano.7b00944 ↗
46. NIR-triggered anticancer drug delivery by upconverting nanoparticles with integrated azobenzene-modified mesoporous silica10.1002/anie.201300183 ↗
47. Biocompatibility of silica coated NaYF(4) upconversion fluorescent nanocrystals10.1016/j.biomaterials.2008.07.012 ↗
48. Toxicity mechanism of low doses of NaGdF(4):Yb(3+), Er(3+) upconverting nanoparticles in activated macrophage cell lines10.3390/biom9010014 ↗
49. Tumor microenvironment-responsive mesoporous MnO2-coated upconversion nanoplatform for self-enhanced tumor theranostics10.1002/adfm.201803804 ↗
50. Enhanced upconversion emission in Yb3+ and Er3+ codoped NaGdF4 nanocrystals by introducing Li+ ions10.1039/C1NR11365H ↗
51. Energy transfer mechanism dominated by the doping location of activators in rare-earth upconversion nanoparticles10.1039/C8CP02142B ↗
52. Differently sized magnetic/upconversion luminescent NaGdF4:Yb, Er nanocrystals: flow synthesis and solvent effects10.1039/C6CC01686C ↗
53. Sub-6 nm monodisperse hexagonal core/shell NaGdF4 nanocrystals with enhanced upconversion photoluminescence10.1039/C6NR08675F ↗
54. MC540 and upconverting nanocrystal coloaded polymeric liposome for near-infrared light-triggered photodynamic therapy and cell fluorescent imaging10.1021/am500097f ↗